✦ LIBER ✦

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

✍ Scribed by Meir Steiner; Angelica Lindén Hirschberg; Richard Bergeron; Fiona Holland; Michelle D. Gee; Elisabeth Van Erp

Book ID: 113429093
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 254 KB
Volume: 193
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2005.01.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mon-P93 - Treatment of premenstrual dysp

Mon-P93 - Treatment of premenstrual dysphoric disorder with fluoxetine during the luteal phase

✍ C. Crnobarić; M. jašović-Gašić; S. Milovanović; Č. Miljevicć 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 131 KB

A placebo-controlled study of the effica

A placebo-controlled study of the efficacy of intermittent and continuous treatment with paroxetine for premenstrual dysphoric disorder (PMDD)

✍ M. Landén; C. Ysander; K. Sörvik; H. Nissbrandt; C. Allgulander; B. Hunter; E. E 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Symptom-onset dosing with citalopram in

Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series

✍ L. N. Ravindran; S.-A. Woods; M. Steiner; A. V. Ravindran 📂 Article 📅 2007 🏛 Springer Vienna 🌐 English ⚖ 59 KB

Patients with premenstrual dysphoric dis

Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects

✍ Elin Bannbers; Kristiina Kask; Johan Wikström; Victoria Risbrough; Inger Sundstr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Changes in mood, cognitive performance a

Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder)

✍ Stephanie Collins Reed; Frances R. Levin; Suzette M. Evans 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 905 KB

Effectiveness and tolerability of paroxe

Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea

✍ Chi-Un Pae; Won-Myong Bahk; Duk-In Jon; Sang-Yeol Lee; Bo-Hyun Yoon; Kyung Joon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled